Robotic surgical console for nerve-sparing radical prostatectomy with 3D pelvic visualization

PROTON THERAPY, PSMA & FUNCTION PRESERVATION

Advanced Prostate Cancer Care in China

Modern prostate cancer treatment aims for complete cancer cure while strictly preserving urinary continence and sexual function. China operates premier particle therapy centers delivering proton and carbon ion radiation that stop precisely inside the prostate, alongside robotic nerve-sparing surgery and targeted PSMA radioligand therapy for advanced disease.

ADVANCED TREATMENT OPTIONS

Key Prostate Cancer Treatments

Proton and carbon ion particle therapy, nerve-sparing robotic surgery, and targeted PSMA radioligand treatments.

Proton & Carbon Ion Radiation

Pinpoint particle beams destroy prostate cancer cells with sub-millimeter precision, causing virtually zero radiation damage to the rectum and bladder.

Robotic Nerve-Sparing Surgery

Da Vinci robotic surgery that meticulously protects the delicate nerves responsible for urinary continence and erectile function.

Targeted PSMA Radioligand Therapy

Precision molecular therapy targeting PSMA receptors on prostate cancer cells to treat widespread or metastatic disease.

WHY CHOOSE US

Why Choose China for Prostate Cancer

A patient-first clinical pathway connecting international men directly with premier urologic oncology centers in China.

China’s national particle radiation centers offer unmatched precision for prostate cancer. Carbon ion beams possess high relative biological effectiveness (RBE), delivering intense double-strand DNA damage to prostate tumors while the steep Bragg peak prevents radiation from touching the rectum and bladder base, virtually eliminating urinary incontinence and rectal bleeding.

For surgical candidates, top academic urology centers perform thousands of robotic radical prostatectomies with precise neurovascular bundle preservation. Transparent public hospital billing and personal bilingual case managers ensure an effortless care experience.

HOW IT WORKS

4 Steps to Treatment in China

A simple, step-by-step process from initial record review to your arrival and treatment in China.

01. Submit Records Online

Upload existing pathology reports, biomarker NGS profiles, and imaging scans through our secure clinical intake portal.

02. Pre-Screen & Doctor Match

Clinical eligibility and contraindication screening, matching your specific case with China's foremost oncology chiefs.

03. Doctor Consultation

One-on-one remote video consultation or written multidisciplinary assessment to confirm treatment protocol before travel.

04. Travel to China & Care

Expedited medical visa support, priority hospital admission, dedicated bilingual bedside escorts, and continuum follow-up.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international patients considering care in China.
Because particle beams stop inside the prostate without exiting into the rectum or bladder, the risk of long-term rectal bleeding or permanent urinary incontinence is drastically lower.
Yes. Both particle beam radiation and robotic nerve-sparing surgery are specifically designed to safeguard the neurovascular bundles controlling continence and potency.
Patients have access to advanced PSMA targeted radioligand therapies, second-generation anti-androgens, and PARP inhibitors for genetic mutations.
Hypofractionated carbon ion protocols can complete treatment in as few as 12 to 16 treatment sessions, significantly shorter than conventional 40-session photon radiotherapy.

CONFIDENTIAL CASE EVALUATION

Start with a Confidential Clinical Case Review

Submit your basic case details below for an initial eligibility review. Our medical team coordinates directly with chief oncologists at top Chinese cancer centers, returning a preliminary assessment and roadmap within 24–48 hours.

✓ Free initial triage  •  ✓ Direct specialist coordination  •  ✓ 100% Confidential

    Prostate Cancer